Coeptis Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2020 to Q3 2022

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Coeptis Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2020 to Q3 2022.
  • Coeptis Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 7, 2022 was 19.5M shares, a 42.9% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 19.5M -14.6M -42.9% Nov 7, 2022 10-Q 2022-11-08
Q2 2022 39M +8.71M +28.8% Aug 1, 2022 10-Q 2022-08-02
Q1 2022 38M +38M Mar 11, 2022 10-K 2022-03-11
Q4 2021 36.4M +34.7M +2033% Nov 15, 2021 10-Q 2021-11-15
Q3 2021 34.2M +32.6M +2050% Aug 16, 2021 10-Q 2021-08-16
Q2 2021 30.3M May 17, 2021 10-Q/A 2021-05-18
Q1 2021 0 May 11, 2021 10-KT 2021-05-11
Q4 2020 1.71M Jan 6, 2021 10-Q 2021-01-11
Q3 2020 1.59M Oct 14, 2020 10-Q/A 2020-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.